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Abstract. Several experimental and clinical studies suggest that the lungs are a
specific target of Mg-hypomagnesemia, which is a common side effect of cyclospo-
rin A therapy. Due to the possible effect of hypomagnesemia on lung allograft
function, the aim of this study was to evaluate endothelial cell (EC) activation and
tissue remodelling (apoptosis) in the lungs from mice fed Mg-deficient diets. Immu-
nocytochemical examinations did not reveal any inflammatory process in
Mg-deficient mice, infiltration of leukocytes (CD45+ cells), expression of I-Ab class II
molecules, E-selectin or ICAM-1 on ECs, and apoptotic cells. Quantification of
mRNAs for E-selectin, ICAM-1 and VCAM-1, which are the most pertinent adhesins
expressed by ECs, and for the cytokines TNFa and IL-2, demonstrated that severe
Mg-deficiency does not result in EC activation. The balance between the
up-regulation of G-CSF-R and CCL4 genes, and the down-regulation of the OPN gene
shown by the cDNA microarray technique might be responsible for the absence of
development of an inflammatory response, lung EC activation, and lung remodel-
ling. However, we can hypothesize that severe Mg deficiency results in a latent
inflammatory status of the lungs, which might be expressed following immune
stresses, like transplantation conditions.
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Magnesium (Mg) is the second most abundant intra-
cellular cation. It plays an essential role in numerous
enzymatic reactions involving energy metabolism
and fundamental cellular reactions [1-3]. It acts as an
ionic membrane regulator and modulator of neu-
ronal and muscle activity of the ion transfer through
membrane channels [4] and stabilizes cellular mem-
branes, organelles like ribosomes, and nucleic acids
[3, 5]. Therefore, it is not surprising that alterations
of Mg homeostasis would lead to metabolic, biologi-
cal, or organic dysfunctions, and cause various clini-
cal disorders. Experimental hypomagnesemia in
weaning or adult rats or mice has been associated
with an early inflammatory process, a decrease of
immune responses, oxidative damage to which neu-
ropeptides like substance P (SP) and calcitonin gene-
related peptide (CGRP) may contribute, and endot-
helial cell dysfunction [6-15]. In vitro, culture of
human umbilical vein endothelial cells (HUVEC) in
low Mg concentrations was shown to inhibit cell
growth and migration, to stimulate monocyte/
endothelial cell interactions, and to up-regulate
plasma plasminogen activator inhibitor (PAI)-1
expression [16].
Endothelial cells (EC) play a crucial role in maintain-
ing the functional integrity of the vascular wall. They
express a panel of markers, including factor VIII/von
Willebrand antigen, platelet/endothelial cell adhe-
sion molecule-1 (PECAM-1 or CD31), vascular endot-
helial cadherin (VE-cadherin or cad-5), and endothe-
lial cell nitric oxide synthase (eNOS). The
endothelium is a highly metabolically active organ






















































that is involved in many physiological processes,
including the control of vasomotor tone, barrier
function, leukocyte adhesion and trafficking, inflam-
mation, and hemostasis [17]. However, profound
structural and functional heterogeneity exists along
the vascular tree, between different organs and
between two adjacent ECs of a single blood vessel
[18, 19]. EC diversity is also reflected at the molecu-
lar and transcriptional levels [18]. Blood vessel type-
specific and tissue-specific characteristics of ECs
are differentially regulated in space and time, and are
under the control of their microenvironment [20].
ECs in the lung express a unique repertoire of genes
and gene products, although heterogeneity also
exists between different segments of the vascular
loop within the lung: microvessels, veins, arteries,
bronchial or pulmonary circulation [19, 21-23]. Sev-
eral experimental and clinical studies have shown a
relationship between Mg status and pulmonary aller-
gies or sudden infant death syndrome (SIDS), sug-
gesting that the lungs might be a specific target of
Mg-deficiency [24, 25]. From epidemic data, magne-
sium may play a role in the control of asthma or in the
development of bronchospasm [26, 27], although
magnesium supplementation does not appear to pro-
vide important clinical benefits in chronic stable
asthma [28, 29]. Indeed, acute asthma was associated
with lower erythrocyte Mg content, while plasma Mg
concentrations remained unchanged [27]. Finally,
Mg deficiency may be considered as an adjuvant
nutritional disorder in asthma, but asthma per se
does not depend only on Mg deficiency [30]. Hypo-
magnesemia is a common side effect of cyclosporin
A (CsA) therapy [31-33]. It is associated with a faster
rate of decline in kidney allograft function and
increased graft loss in renal transplant recipients
with chronic CsA nephropathy [34, 35]. Moreover,
magnesium deficiency enhances the susceptibility of
rat hearts to ischemia-reperfusion injury [36]. Con-
versely, it has been reported that the addition of ATP
and MgCl2 to the preservation solution attenuated
reperfusion injury following cold ischemia in rat
lungs [37].
Because of a possible effect of hypomagnesemia on
lung allograft function, the aim of this study was to
evaluate EC activation and tissue remodelling (apop-
tosis) in lungs from mice fed a Mg-deficient diet. We
analyzed the mRNA expression of a number of
endothelial adhesion molecules (ICAM-1 or CD54,
VCAM-1 or CD106, E-selectin or CD62E), which are
expressed in the lung in inflammatory conditions and
are of eminent importance for the migration of leu-
kocytes to sites of inflammation. We quantified the
major inflammatory cytokine tumor necrosis factor
alpha (TNFa) and also IL-2, which plays a pivotal role
in the initiation of an immune response leading to the
induction of lymphocyte proliferation. These two
cytokines influence manifold cells involved in
inflammatory processes and graft rejection.
Materials and methods
Animals and diet
Female C57BL/6NHsd 6 week-old mice (Harlan, Gan-
nat, France) were given ad libitum for 26 days,
either standard Mg-containing diet (control diet,
1400 ppm Mg2+, Harlan Teklad 2016 batch n° M013)
and tap water for drinking (< 4 ppm Mg2+), or syn-
thetic Mg-deficient diets (150 or 50 ppm Mg2+) pre-
pared in the laboratory and deionized water to avoid
consumption of Mg from normal drinking water.
Mice were maintained at +22°C. All experiments
were performed according to the recommendations
of the INRA Ethics Committee (decree no. 87-848).
At days 5, 14 and 26, control and Mg-deficient mice
(n = 6 per group) were anesthetized with avertin
(250 mg/kg, intraperitoneally) and injected with hep-
arin (25,000 IU/kg intraperitoneally) as anticoagulant
protocol. Blood was collected by heart-puncture.
Lungs were excised: one part was immediately fro-
zen in liquid nitrogen then stored at -80°C for histo-
logical and immunocytochemical studies, while total
RNA was extracted from a second part and total
proteins from a third part.
Blood determinations
Mg concentration in plasma was determined by a
xylidyl blue complexometric method by routine pro-
cedures in an automated clinical biochemistry facil-
ity (AU400, Olympus, Rungis, France).
White cell count and leukocyte formula were per-
formed in an automaton (ABX Pentra Vega
Retic/ABX Hemato, Montpellier, France).
TNF-a quantification in lung extracts
Fresh lungs were sonicated 3 times for 10 sec on ice
in a lysis solution containing 50 mM Tris/HCl, 150 mM
NaCl, 1 mM dithiothreitol, 0.5 mM EDTA, 0.25 mM
Na3VO4 (a protein tyrosine phosphatase inhibitor),
0.5% (w/v) sodium deoxycholate, 0.1% (w/v) SDS,
1 lg/mL aprotinin (a serine protease inhibitor) and
1 lg/mL leupeptin (an inhibitor of serine and cys-
teine proteases). These extracts were kept frozen at
-80°C until use.
Total proteins were quantified by the Biuret colori-
metric method (BC Assay Kit, Interchim, Montluçon,






















































France) according to the manufacturer’s instruc-
tions. Results were expressed in lg/ml by using a
reference curve ranging from 50 to 250 lg of bovine
serum albumin /ml.
TNFa was quantified in protein extracts by an
enzyme-linked immunosorbent assay (ELISA)
(Quantitine® M Murine, mouse TNFa, R&D Systems
Europe, Lille, France) according to the manufactur-
er’s instructions. Results were expressed in pg/ml by
using a reference curve ranging from 23.4 to 1500
pg/ml. The minimum detectable dose was less than
5.1 pg/ml. Levels of TNFa were recorded as pg/mg of
total proteins.
Histological and immunocytochemical studies
For histological observation, haematoxylin (Harris
haematoxylin, 10 sec)-eosin (eosin 225 for histology,
10 sec) staining was performed on cryostat sections
fixed with acetone for 10 min.
The expressions of I-Ab, E-selectin, ICAM-1, and
CD45 were analyzed on 7 lm cryostat sections.
Endothelial cells were identified by the expression of
factor VIII/von Willebrand antigen by using poly-
clonal rabbit anti-von Willebrand factor (vWf) immu-
noglobulin fraction (DakoCytomation S.A., Trappes,
FRANCE), then fluorescein isothiocyanate (FITC)- or
TRITC-conjugated goat (Fab’)2 fragment anti-rabbit
IgG (Beckman Coulter, Marseille, France). Double-
stainings were performed using the following spe-
cific and secondary antibodies: biotinylated mouse
anti-I-Ab IgG2a (BD Biosciences, Le Pont de Claix,
France), then streptavidin-Texas Red (Amersham
Life Science, Orsay, France); biotinylated rat anti-
mouse E-selectin IgG2a mAb (BD Biosciences, Le
Pont de Claix, France), then Alexa594-conjugated
streptavidin (Molecular Probes, Montluçon, France);
biotinylated polyclonal goat IgG anti-mouse ICAM-1
(R&D Systems, Lille, France), then streptavidin-
Texas Red; rat IgG2b anti-mouse CD45 mAb (R&D
Systems, Lille, France), which reacts with leukocyte
common antigen expressed on all types of leuko-
cytes, then FITC-conjugated rabbit polyclonal IgG
anti-rat (Serotec, Cergy Saint-Christophe, France).
Irrelevant immunoglobulins were used as negative
controls for the specific mAbs.
Detection of apoptotic cell death was conducted
on 7 lm cryostat sections using a commercially
available TUNEL (TdT-mediated dUTP-X nick end
labeling) method (In Situ Cell Death Detection kit,
Fluorescein, Roche Diagnostics, Meylan, France),
according to the manufacturer’s instructions. To
identify apoptotic endothelial cells, double staining
was performed using polyclonal rabbit anti-vWf
immunoglobulin fraction, then TRITC- conjugated
goat (Fab’)2 fragment anti-rabbit IgG2a monoclonal
antibody.
mRNA quantification in lung tissue by SYBR
Green real-time RT-PCR
Total RNA extraction from fresh lung, reverse tran-
scription and quantitative PCR using the LightCyc-
lerTM method (Roche Diagnostics, Meylan France)
were carried out as previously described [38]. The
primers for E-selectin, VCAM-1, ICAM-1, TNFa , and
IL-2 cDNA amplification were selected by using
Oligo-4 software (Med Probe, Oslo, Norway) to limit
self-complementarity and to optimize sequence
specificity [38, 39]. They were synthesized by Euro-
bio (Les Ulis, France). Results were expressed as
arbitrary units (A.U.) using a single external standard
curve (log concentration versus number of cycles)
obtained from dilutions of a specific standard cDNA
amplification product, and after standardization for
GAPDH housekeeping gene. For length and specific-
ity verification, amplimers were separated by elec-
trophoresis onto a 1.5% agarose gel.
Gene expression analysis of lung tissue by
the cDNA microarray technique
Gene expression was analyzed in lung tissue after 26
days of Mg-deficient diet (50 ppm Mg) using topic-
defined PIQORTM Cytokines & Receptors (274
genes) Mouse Microarray (Memorec Biotec GmbH,
Köln, Germany). PIQORTM Microarray experiments
allow the identification of genes that are differen-
tially expressed in different samples and the com-
parison of gene expression profiles in lung tissues
from normal and Mg-deficient mice. The resulting
data enable to compare amounts of specific RNAs
between RNA samples.
A minimum of 50 lg total RNA per sample is
required; otherwise cDNA amplification is needed.
In a first step, quality of total RNA was controlled.
Total RNA quality was checked by the Agilent 2100
Bioanalyzer system (Agilent Technologies, Massy,
France), which gives electrophoregram with a RNA
ladder reference in kB and elution diagrams (fluores-
cence versus elution time). The two prominent
peaks within the elution diagrams represent riboso-
mal 28S and 18S RNAs. The peak areas of 28S and 18S
RNAs were determined and the ratio of 28S/18S was
calculated. A value greater than 1.5 indicates qualita-
tive integrity of the RNAs.
The second step was hybridization of PIQORTM
Microarray. Cy3- or Cy5-probe labelling by reverse
transcription was performed according to the






















































PIQORTM Instruction Manual. The fluorescent
labelled probes were subsequently hybridized on
topic-defined PIQORTM Cytokines & Receptors
Mouse Sense Microarray and subjected to overnight
hybridization using a hybridization station.
In a third step, the signal generated by the hybrid-
ization of a labelled, complementary nucleic acid
sequence to an arrayed cDNA was detected and
quantified using a scanner and appropriate software.
Scanned Cy3 and Cy5 images were overlaid. Red
colour indicates that the Cy5 signal intensity is
higher than the Cy3 signal intensity. The respective
gene is therefore overexpressed in the respective
sample. Green spots indicate that the fluorescence
intensity in the control sample is stronger induced
than in the experimental sample. Yellow spots indi-
cate that the signal intensities are equal for both
probes. Each gene was spotted on 4 different posi-
tions on the array. Results for each gene are
expressed as Cy5/Cy3 ratio and the respective coeffi-
cient of variation (CV in %, which refers to the aver-
age of the expression ratios of 4 spot replicates).
A < 0.58-fold down-regulation or a >1.7-fold induc-
tion of a gene in comparison to the control sample
was considered as relevant.
Data analysis
The results of plasma Mg2+, white blood cell count,
mRNAs and TNFa quantification were recorded for
each test group as mean values with SEM. The non-
parametric Mann-Whitney t test was used. A p value
of p < 0.05 was considered significant.
Results and discussion
Mice fed a Mg-deficient diet exhibited normal growth
curve, since body weights at days 5, 14 and 26 were
similar in mice fed normal or deficient diet. Mice fed
a 50 ppm Mg-diet exhibit a dramatic decrease in Mg
concentration in plasma starting from day 5
(0.92 ± 0.11 mmol/l versus 1.31 ± 0.04 in control
mice, p < 0.01 at day 5; 0.58 ± 0.09 mmol/l versus
1.18 ± 0.15, p < 0.01, at day 14; 0.53 ± 0.07 mmol/l
versus 1.23 ± 0.09, p < 0.01, at day 26) (figure 1).
However only a transient increase in the number of
blood neutrophils (1.3 fold, p < 0.05) was observed at
day 5, without any changes in total leukocytes or
lymphocyte populations. By contrast, in mice fed a
150 ppm Mg-diet, Mg concentrations were tran-
siently decreased (figure 1) only at day 5 (1.13 ± 0.14
mmol/l versus 12.37 ± 0.13 in control mice, p < 0.05)
and accompanied by a transient increase (1.6 fold,
p < 0.01) in the number of blood leukocytes, both
neutrophils (1.86 fold, p < 0.05) and lymphocytes
(1.46 fold, p < 0.05). These data are in contradiction
to previous studies in rats, which demonstrated that
Mg deficiency is responsible for a non-specific
inflammatory response characterized by an increase
in the number and activation of blood neutrophils [7,
40]. The return of plasma Mg to a normal level follow-
ing the moderate decrease observed as early as fol-
lowing 5 days of 150 ppm Mg-diet, may be related to a
compensatory phenomenon with either the activa-
tion of intestine Mg-carriers, which leads to an
increased intake of Mg from the diet, or the mobiliza-
tion of the intracellular Mg pool.
At the level of lungs, our histological studies did
not reveal any inflammatory process in Mg-deficient
mice. No infiltration of leukocytes (CD45+ cells) was











































Figure 1. Concentration of Mg2+ (mmol/l) in plasma
from mice fed either the control or a Mg-deficient
diet (50 or 150 ppm Mg) for 5, 14 and 26 days. Data
are mean ± SEM of 6 mice. *p < 0.05 and **p < 0.01
versus control diet.






















































Data on the increase in proinflammatory cytokine
production in blood from Mg-deficient rats are con-
flicting. Elevated levels of TNFa, IL-1b and IL-6
within 3 weeks of Mg deprivation were reported in
rats by Weglicki et al. [41]. By contrast, only elevated
levels of IL-6 were reported by Malpuech-Brugere et
al. in weanling rats without a concomitant increase
in TNFa , which was undetectable [7]. Again, data on
the effect of endotoxin challenge on plasma TNFa
levels in Mg-deficient rats are unclear. Nakagawa et
al. [42] demonstrated that serum TNFa was detected
neither in control nor in Mg-deficient rats aged 7-9
weeks, but increased after endotoxin challenge with-
out significantly larger amounts in Mg-deficient rats
than in controls, which was in contradiction to
Malpuech-Brugere et al. who showed a significantly
higher TNFa plasma value in weaning rats fed a
Mg-deficient diet for 7 days than control rats follow-
ing endotoxin challenge [43].
However, the effect of Mg-deficiency on TNFa
expression in lungs has not been reported. In our
studies, the levels of TNFa in lung extracts were not
altered in Mg-deficient mice compared to control
mice throughout the experiment, and were around 3
pg/mg of proteins.
We then investigated the effects of Mg-deficiency
upon lung activation by the quantification of mRNAs
for the most pertinent adhesins expressed by lung
ECs and for the cytokines TNFa and IL-2. In mice fed
50 ppm Mg-diet, the level of VCAM-1 mRNA was
transiently significantly decreased at day 14
(0.30 A.U. ± 0.11 versus 0.45 A.U. ± 0.10, in Mg-
deficient and control mice, respectively, p < 0.05).
E-selectin mRNA was undetectable and the levels of
ICAM-1, IL-2 and TNFa mRNAs were not signifi-
cantly different between the two groups (figure 2).
This last result is in keeping with the similar amounts
of TNFa evidenced by ELISA in the lungs from both
Mg-deficient and control mice. Surprisingly, in mice
fed a 150 ppm Mg-diet, the level of TNFa mRNA was
transiently significantly increased at day 5
(0.039 A.U. ± 0.016 versus 0.016 A.U. ± 0.010, in
Mg-deficient and control mice, respectively,
p < 0.05), then ICAM-1 at day 14 (1.12 A.U. ± 0.4 ver-
sus 0.64 A.U. ± 0.26, in Mg-deficient and control
mice, respectively, p < 0.05), and ultimately VCAM-1
at day 26 (1.31 A.U. ± 0.26 versus 0.88 A.U. ± 0.19, in
Mg-deficient and control mice, respectively, p < 0.05)
(figure 3). These results suggest that the activation
of the proinflammatory cytokine TNFa in the lung is
an early event, which in turn leads to lung EC activa-
tion with the successive overexpression of the
adhesins ICAM-1 then VCAM-1. Hence, the absence
of activation of adhesion molecule expression
observed in mice fed a 50 ppm Mg-diet could tie up
with the fact that no TNFa up-regulation occurred.
IL-2 mRNA levels were not significantly different
between Mg-deficient and control mice, and
E-selectin mRNA was undetectable. Since ICAM-1
and VCAM-1 are the most important members of the
immunoglobulin superfamily for EC-T cell interac-
tions [44], the absence of T-cell activation to produce
IL-2 may be the consequence of poor EC activation.
Cytokines strongly influence the expression of adhe-
sion molecules on ECs and form a complex commu-
nication network causing results which are deter-
mined by the interaction of several cytokines [45].
Therefore, it has to be taken into consideration that,
apart from TNFa and IL-2, other cytokines, including
cytokines secreted by ECs themselves, may be
involved in the different patterns of expression of the
adhesion molecules observed in lungs from mice
given a 50 or 150 ppm Mg-diet.
Double-staining and immunofluorescence exami-
nation obviated no expression of I-Ab class II mol-
ecule, E-selectin or ICAM-1 on ECs identified by the
expression of von Willebrand antigen, confirming the
absence of EC activation. Consequently, the absence
of EC or lung cell apoptosis demonstrated by the
TUNEL method was not surprising. These results are
in agreement with the observation that adhesion of
monocyte-like U937 cells to ECs cultured in
Mg-deficient medium was increased without any rel-
evant induction of the well characterized adhesion
molecules VCAM, ICAM, E-selection and P-selectin
expression [16].
All our findings demonstrate that in our model in
mice, severe Mg-deficiency does not result in an
inflammatory process and remodelling in lungs,
which is in contradiction to Nasulewicz et al who
have recently demonstrated that severe
Mg-deficiency in mice was associated with signifi-
cant changes in the expression of genes and resulted
in inflammatory and oxidative processes and con-
secutive remodelling in lung tissue [46]. By contrast,
our results suggest that moderate Mg-deficiency
induce an early but transient inflammatory process
and EC activation, which appear to be overcome
with time. However, these mice were older, from a
different breeding centre and of a different strain,
which may explain our particular immunological pat-
tern.
To further confirm our findings, which appeared to
be in contradiction to the literature, we identified
genes differently expressed in the lungs of
Mg-deficient mice after 26 days of 50 ppm Mg2+-diet,
using cDNA microarrays for mRNA expression






















































analysis. A total of 274 genes encoding for cytokines,
chemokines, growth factors and receptors were ana-
lyzed. In conditions of severe Mg deficiency (26 days
of 50 ppm Mg-diet), we found that a gene coding for
G-CSF-R (granulocyte colony stimulating factor
receptor precursor = CD114 antigen) was markedly
up-regulated (2.08 fold versus control mice, with a
coefficient of variation of 4%). G-CSF-Rs are high-
affinity receptors for G-CSF, which have been
reported on hematopoietic cells but also on nonhe-
matopoietic cell types, including vascular EC and
cells from the lung. G-CSF is the major regulator of
neutrophil production, differentiation and activa-
tion, and induces human ECs to migrate and prolifer-
ate [47]. G-CSF-R has no intrinsic kinase activity but
recruits cytoplasmic tyrosine kinases and ultimately
activates signal transducer and activator of tran-
scription (STAT) proteins [48]. STAT3 has been impli-
cated in G-CSF-mediated growth arrest preceding
differentiation, while activation of STAT5 has been
linked to proliferation and survival signalling. Inter-
estingly, G-CSF was shown to induce anti-apoptotic
proteins and to inhibit apoptotic death [49]. Hence,











































Figure 2. Quantitative expression of ICAM-1, VCAM-1, TNFa and IL-2 mRNAs by real-time RT-PCR in lungs
from mice fed either the control or 50 ppm Mg diet for 5, 14 and 26 days. Results are expressed as arbitrary
units (A.U.). Data are mean ± SEM of 6 mice. *p < 0.05 versus control diet.






















































TUNEL method may be related to G-CSF-R
up-regulation.
A gene coding for the chemokine CCL4 (macroph-
age inflammatory protein 1-beta = MIP-1b) produced
by the hematopoietic cells was also found to be
up-regulated (2.26 fold) but with a coefficient of
variation of 34%. CCL4, like CCL3 (macrophage
inflammatory protein 1-alpha = MIP-1a) is a mono-
cyte chemoattractant and coactivator. Additionally,
the MIP-1 proteins have chemoattractant and adhe-
sive effects on lymphocytes. They orchestrate acute
and chronic inflammatory host response at sites of
injury or infection mainly by recruiting proinflamma-
tory cells. During allograft rejection, early CCL4
intragraft expression (1.5-48 h after cardiac trans-
plant) was found to be T cell dependent and
increased significantly with time after transplanta-
tion [50]. MIP-1 proteins mediate their biological
effects by bonding to cell surface CC chemokine














































Figure 3. Quantitative expression of ICAM-1, VCAM-1, TNFa and IL-2 mRNAs by RT-PCR in lungs from mice
fed either the control or 150 ppm Mg diet for 5, 14 and 26 days. Results are expressed as arbitrary units (A.U.).
Data are mean ± SEM of 6 mice. *p < 0.05 versus control diet.






















































the G-protein-coupled receptor superfamily. How-
ever, the exact downstream events induced by CCL3
and CCL4 remain to be characterized [51].
By contrast, a gene coding for the osteopontin
precursor was found to be down-regulated by severe
Mg-deficiency (0.45 fold with a coefficient of varia-
tion of 4%). Osteopontin (OPN) is one of the major
extracellular proteins called matricellular proteins
(MCP) involved in cell to matrix communication and
in several inflammatory diseases by regulating
inflammatory cell accumulation and function at sites
of inflammation and repair, through inhibition of
nitric oxide (NO) expression [52]. It is also a known
chemoattractant for macrophages and neutrophils.
OPN acts as a survival, cell-adhesive, and chemotac-
tic factor for ECs, induces EC migration and
up-regulates EC migration induced by vascular
endothelial growth factor (VEGF), protects ECs
from apoptosis via NF-jB activation [53, 54]. OPN
acts as a cytokine that plays important roles in
monocyte/macrophage functions. It was shown to be
strongly expressed on alveolar macrophages in
inflammatory lung situations like acute respiratory
distress syndrome, where it might play a protective
role against excessive production of NO [55]. It is
interesting to point out that, like OPN in our model,
several genes responsible for EC proliferation and
migration, and for the adhesion of EC to substratum
were found to be down-regulated by culture in low
Mg medium [16].
Conclusions
In our model of severe hypomagnesemia in mice, the
balance between the up-regulation of G-CSF-R and
CCL4 genes, and the down-regulation of OPN gene
might be responsible for the absence of development
of an inflammatory response, lung EC activation, and
lung remodelling, despite an enhanced mRNA
expression of chemoattractant factors for neutro-
phils and macrophages. However, we can hypoth-
esize that severe Mg-deficiency induces a latent
inflammatory status of lungs, which might be
revealed following stresses, particularly immune
stresses. We are currently investigating this hypoth-
esis in our experimental model of isolated mouse
lung perfused in allogeneic conditions, which mim-
ics lung transplantation conditions.
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